Cargando…
Determination and pharmacokinetic study of AZD‐3759 in rat plasma by ultra performance liquid chromatography with triple quadrupole mass spectrometer
BACKGROUND: AZD‐3759 is a new, potent, oral, active central nervous system‐penetrant EGFR inhibitor. Despite promising clinical activity among patients pretreated and never treated with EGFR‐tyrosine kinase inhibitors, no time saving pharmacokinetic study method has been reported in an animal model....
Autores principales: | Wu, Qingjun, Hua, Ailian, Sun, Yaoguang, Ma, Chao, Tian, Wenxin, Huang, Chuan, Yu, Hanbo, Jiao, Peng, Wang, Shuanghu, Tong, Hongfeng, Qiu, Weiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209780/ https://www.ncbi.nlm.nih.gov/pubmed/30252204 http://dx.doi.org/10.1111/1759-7714.12843 |
Ejemplares similares
-
Pharmacokinetics and Metabolite Profiling of Trepibutone in Rats Using Ultra-High Performance Liquid Chromatography Combined With Hybrid Quadrupole-Orbitrap and Triple Quadrupole Mass Spectrometers
por: Sun, Zhi, et al.
Publicado: (2019) -
AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
por: Yin, Wei, et al.
Publicado: (2021) -
Determination and Pharmacokinetics of Okanin in Rat Plasma by UltraHigh Performance Liquid Chromatography Coupled with Triple-Quadrupole Tandem Mass Spectrometry
por: Shi, Yurui, et al.
Publicado: (2020) -
Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
por: Tian, Wenxin, et al.
Publicado: (2020) -
AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1
por: Zhao, Ruing, et al.
Publicado: (2021)